A 5‑year evaluation of chemoprophylactic treatment in elementary school children with subclinical leprosy

• Main Authors: Linda Astari, -, Nastiti Intan Permata Sari, -, Kusnartedjo Nanang, -, Edy Cahyono, -, Nanny Herwanto, -, Muhammad Yulianto Listiawan, -, Dinar Adriaty, -, Iswahyudi, -, Ratna Wahyuni, -, Medhi Denisa Alinda, -, Bagus Haryo Kusumaputra, -, Regita Indira Agusni, -, Indropo Agusni, -, Shinzo Izumi, -, Cita Rosita Sigit Prakoeswa, -
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Spandidos Publications 2021
• Subjects: R Medicine (General); RL Dermatology
• Online Access: https://repository.unair.ac.id/119570/1/Karil.pdf; https://repository.unair.ac.id/119570/2/Artikel.pdf; https://repository.unair.ac.id/119570/3/Similarity.pdf; https://repository.unair.ac.id/119570/; https://www.spandidos-publications.com/10.3892/br.2021.1464; https://doi.org/10.3892/br.2021.1464
• Institution: Universitas Airlangga

Subclinical leprosy is an infectious disease in which the immune system remains infected with Mycobacterium leprae (M. leprae). The progress of subclinical leprosy to clinical cases within 1 year of infection is 1.5%, with an increase to 6% in the following 4 years. Rifampicin is frequently used for...